130 related articles for article (PubMed ID: 9733769)
21. High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2.
Swain M; Slomiany MG; Rosenzweig SA; Atreya HS
Arch Biochem Biophys; 2010 Sep; 501(2):195-200. PubMed ID: 20541521
[TBL] [Abstract][Full Text] [Related]
22. Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.
Kalus W; Zweckstetter M; Renner C; Sanchez Y; Georgescu J; Grol M; Demuth D; Schumacher R; Dony C; Lang K; Holak TA
EMBO J; 1998 Nov; 17(22):6558-72. PubMed ID: 9822601
[TBL] [Abstract][Full Text] [Related]
23. Cooperativity of the N- and C-terminal domains of insulin-like growth factor (IGF) binding protein 2 in IGF binding.
Kuang Z; Yao S; McNeil KA; Thompson JA; Bach LA; Forbes BE; Wallace JC; Norton RS
Biochemistry; 2007 Dec; 46(48):13720-32. PubMed ID: 17985932
[TBL] [Abstract][Full Text] [Related]
24. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.
Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM
Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
26. Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model.
Galiano RD; Zhao LL; Clemmons DR; Roth SI; Lin X; Mustoe TA
J Clin Invest; 1996 Dec; 98(11):2462-8. PubMed ID: 8958208
[TBL] [Abstract][Full Text] [Related]
27. Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity.
Jansson M; Dixelius J; Uhlen M; Nilsson BO
FEBS Lett; 1997 Oct; 416(3):259-64. PubMed ID: 9373165
[TBL] [Abstract][Full Text] [Related]
28. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3.
Spencer EM; Chan K
Prog Growth Factor Res; 1995; 6(2-4):209-14. PubMed ID: 8817663
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions.
Pell JM; Hill RA; Stewart CE; Weston CR; Flick-Smith HC
Endocrinology; 2000 Feb; 141(2):741-51. PubMed ID: 10650956
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development.
Denley A; Wang CC; McNeil KA; Walenkamp MJ; van Duyvenvoorde H; Wit JM; Wallace JC; Norton RS; Karperien M; Forbes BE
Mol Endocrinol; 2005 Mar; 19(3):711-21. PubMed ID: 15576456
[TBL] [Abstract][Full Text] [Related]
31. Alanine screening mutagenesis establishes tyrosine 60 of bovine insulin-like growth factor binding protein-2 as a determinant of insulin-like growth factor binding.
Hobba GD; Löthgren A; Holmberg E; Forbes BE; Francis GL; Wallace JC
J Biol Chem; 1998 Jul; 273(31):19691-8. PubMed ID: 9677398
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the C-terminal part of insulin-like growth factor (IGF)-binding protein-1 result in dimer formation and loss of IGF binding capacity.
Brinkman A; Kortleve DJ; Zwarthoff EC; Drop SL
Mol Endocrinol; 1991 Jul; 5(7):987-94. PubMed ID: 1719384
[TBL] [Abstract][Full Text] [Related]
34. The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5.
Zesławski W; Beisel HG; Kamionka M; Kalus W; Engh RA; Huber R; Lang K; Holak TA
EMBO J; 2001 Jul; 20(14):3638-44. PubMed ID: 11447105
[TBL] [Abstract][Full Text] [Related]
35. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
Hodgson DR; May FE; Westley BR
Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
[TBL] [Abstract][Full Text] [Related]
36. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs.
Clemmons DR; Dehoff ML; Busby WH; Bayne ML; Cascieri MA
Endocrinology; 1992 Aug; 131(2):890-5. PubMed ID: 1379166
[TBL] [Abstract][Full Text] [Related]
37. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D.
Claussen M; Kübler B; Wendland M; Neifer K; Schmidt B; Zapf J; Braulke T
Endocrinology; 1997 Sep; 138(9):3797-803. PubMed ID: 9275067
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor binding protein-2: contributions of the C-terminal domain to insulin-like growth factor-1 binding.
Kibbey MM; Jameson MJ; Eaton EM; Rosenzweig SA
Mol Pharmacol; 2006 Mar; 69(3):833-45. PubMed ID: 16306230
[TBL] [Abstract][Full Text] [Related]
39. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
Lüthi C; Roth BV; Humbel RE
Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the binding network of IGF-I on the cavity surface of IGFBP4.
Chen X; Zhu S; Duan D; Wu T; Wang Q
J Mol Model; 2013 Dec; 19(12):5257-66. PubMed ID: 24132350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
